Current Statements and Work Group Reports

AAAAI statements are not to be construed as dictating an exclusive course of action; nor are they intended to replace the medical judgment of healthcare professionals. The unique circumstances of individual patients and environments are to be taken into account in any diagnosis and treatment plan. AAAAI statements reflect clinical and scientific advances as of the date of their publication and are subject to change.

Listed below are the current statements of the American Academy of Allergy, Asthma & Immunology. These statements are divided into three categories: position statements, systematic reviews, and work group reports.

A Work Group Report is a narrative review that provides further comment or clarification on appropriate methods of treatment or care. They are generally created by committees or work groups, and the end goal is to aid practitioners in clinical decision making. They are well referenced and contain an appropriate bibliography. They are not guidelines, but do aid in making decisions for patient care. They do not constitute an official opinion or statement of the AAAAI but serve to bring attention to key clinical or even controversial issues.

A Position Statement examines an aspect or aspects of clinical practice, research, or public policy pertaining to allergic/immunologic disease, and through literature review and a consensus of experts, sets forth a position designed to outline appropriate care, appropriate application of research, or public policy. They are well referenced and contain an appropriate bibliography. Position Statements are infrequent, and constitute official positions of the AAAAI.

A Systematic Review examines an aspect or aspects of clinical practice, research or public policy pertaining to allergic/Immunologic disease in a systematic, reproducible fashion. Most such reviews will address therapies, but proposals focusing on other areas – including diagnosis, prevention, or prognosis – are also encouraged. It is expected that authors will define a question, perform a literature search with specified inclusion and exclusion criteria, abstract and critically appraise data according to methodologic quality and assessment of validity, and transparently describe the overall results of the review and how to apply these results to patient care. These reviews do not constitute official statements or policy of the AAAAI, but do carry the potential for meaningful impact.

Surveys
The PDT Committee leadership reviews and approves proposals for surveys of and from AAAAI members because these are often linked to the development of Work Group Reports. Members should start by completing the survey request form and be aware of the AAAAI survey data ownership policy. Surveys approved through the PDT Process must be administered through the AAAAI to maintain compliance with the terms of the data ownership policy. Due to the high number of requests received, individual surveys are sent to a 20% randomly selected representative sample of the AAAAI membership. Any group that would only conduct its survey through an external data collection system would be considered an external collaboration, and thus have to be approved by AAAAI leadership as opposed to through PDT.

Lifespan of AAAAI Statements
After five years from the date of publication, AAAAI position statements and work group reports are not to be considered to reflect current AAAAI standards or policy. The AAAAI maintains these statements in archives for the purpose of reference only.
Click here to find out how to proceed with development of a work group report, position statement or systematic review.

Current Position Statements and Work Group Reports

Penicillin Allergy Evaluation Should Be Performed Proactively in Patients with a Penicillin Allergy Label – A Position Statement of the American Academy of Allergy, Asthma & Immunology (August 2023)

The Impact of Prior Authorization in Allergy/Immunology: A Position Statement of the American Academy of Allergy, Asthma & Immunology. (February 2023)

Special Article: COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic (March 2020)

Allergen Immunotherapy

Allergic Disease

Anaphylaxis

Asthma

Drug Allergy

Food Allergy

Health Disparities

Mast Cell Disorders

Primary Immunodeficiency

Outdoor Allergies

Telemedicine

Technology

Wellness

Archived Position Statements and Work Group Reports
Quality Measures and Their Importance to Allergy/Immunology - The Journal of Allergy and Clinical Immunology: In Practice (Janaury 2015)